Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 11/20 | 0.38 |
| ▸ | HTR6 | P50406 | 8/20 | 0.38 |
| ▸ | HTR1A | P08908 | 7/20 | 0.38 |
| ▸ | DRD2 | P14416 | 7/20 | 0.38 |
| ▸ | HTR2A | P28223 | 7/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | GPR68 | Q15743 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18062209 | 0.95 | CA1 (0.41) | CA9CA1CA2CXCR4HTR7 | |
| SCHEMBL9528787 | 0.95 | CA1 (0.40) | CA9CA1CA2CXCR4HTR7 | |
| SCHEMBL17577086 | 0.93 | CA1 (0.39) | CA9CA1CA2CXCR4HTR7 | |
| SCHEMBL380440 | 0.87 | CA1 (0.47) | CA9CA1CA2HTR7HTR6 | |
| SCHEMBL22931512 | 0.87 | HRH3 (0.44) | CA9CA1CA2CXCR4HTR7 | |
| SCHEMBL14128217 | 0.86 | HRH3 (0.47) | CA9CA1CA2HTR7HTR6 | |
| SCHEMBL18466743 | 0.85 | HSP90AA1 (0.37) | CA9CA1CA2CXCR4HTR7 | |
| SCHEMBL15294299 | 0.84 | HTR7 (0.45) | CA9CA1CA2HTR7HTR6 | |
| SCHEMBL430482 | 0.84 | CXCR4 (0.40) | CA9CA1CA2CXCR4CA12 | |
| SCHEMBL17826472 | 0.83 | LMNA (0.45) | CA9CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110885394-A | Triazine group modified macroporous resin and preparation method thereof | 万华化学集团股份有限公司 | 2020-03-17 | — | — | CN | claimed |
| US-12404287-B2 | Chemical compound, surface treating agent, surface treating method, and production method for metal-resin composite | MEC COMPANY LTD. (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-118420553-B | Compound, surface treatment agent, surface treatment method, and method for producing metal-resin composite | MEC股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-20240270763-A1 | CHEMICAL COMPOUND, SURFACE TREATING AGENT, SURFACE TREATING METHOD, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | MEC COMPANY LTD. (JP) | 2024-08-15 | — | — | US | disclosed |
| EP-4410798-A1 | CHEMICAL COMPOUND, SURFACE TREATING AGENT, SURFACE TREATING METHOD, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | MEC COMPANY., LTD. (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-118420553-A | Compound, surface treatment agent, surface treatment method, and method for producing metal-resin composite | MEC股份有限公司 | 2024-08-02 | — | — | CN | disclosed |
| WO-2023067121-A1 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023067125-A1 | OLIGOSACCHARIDE COMPLEXES AND USES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023067123-A1 | OLIGOSACCHARIDE COMPLEXES AND USES | BioNTech SE (DE) | 2023-04-27 | — | — | WO | disclosed |
| CN-110885394-B | Triazine group modified macroporous resin and preparation method thereof | 万华化学集团股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-110885394-A | Triazine group modified macroporous resin and preparation method thereof | 万华化学集团股份有限公司 | 2020-03-17 | — | — | CN | disclosed |
| EP-2298839-B1 | WEATHER-RESISTANT DYE AND THE USE THEREOF | ZHUHAI NINESTAR MAN CO LTD (CN) | 2017-05-31 | — | — | EP | disclosed |
| US-9382215-B2 | Therapeutic methods and agents for treating myotonic dystrophy | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2016-07-05 | — | — | US | disclosed |
| US-20140288080-A1 | THERAPEUTIC METHODS AND AGENTS FOR TREATING MYOTONIC DYSTROPHY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2014-09-25 | — | — | US | disclosed |
| US-8754084-B2 | Therapeutic methods and agents for treating myotonic dystrophy | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2014-06-17 | — | — | US | disclosed |
| US-20130261124-A1 | THERAPEUTIC METHODS AND AGENTS FOR TREATING MYOTONIC DYSTROPHY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2013-10-03 | — | — | US | disclosed |
| CN-102066451-A | Hyperbranched polymers and oligomers containing terminal amino groups as curing agents for epoxy resins | BASF SE | 2011-05-18 | — | — | CN | disclosed |
| EP-0179408-B1 | AMIDOALKYL MELAMINES AND AMINOALKYL MELAMINES, AND PROCESS FOR THEIR PREPARATION | BASF Aktiengesellschaft (DE) | 1993-09-08 | — | — | EP | disclosed |
| US-4670558-A | POLYURETHANE INTERMEDIATES | BASF AKTIENGESELLSCHAFT (DE) | 1987-06-02 | — | — | US | disclosed |
| EP-0179408-A2 | Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation | BASF Aktiengesellschaft (DE) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288080-A1 | THERAPEUTIC METHODS AND AGENTS FOR TREATING MYOTONIC DYSTROPHY | POLRMT, SMN1; SMN2, MTPN | CA9 4662/4885CA1 4676/4885CA2 3528/4885 |
| US-12404287-B2 | Chemical compound, surface treating agent, surface treating method, and production method for metal-resin composite | ASH2L, H1-0, MARS1 | CA9 1540/4885CA1 537/4885CA2 957/4885 |
| US-20130261124-A1 | THERAPEUTIC METHODS AND AGENTS FOR TREATING MYOTONIC DYSTROPHY | POLRMT, SMN1; SMN2, MTPN | CA9 4662/4885CA1 4676/4885CA2 3528/4885 |
| US-20240270763-A1 | CHEMICAL COMPOUND, SURFACE TREATING AGENT, SURFACE TREATING METHOD, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | ASH2L, H1-0, MARS1 | CA9 1540/4885CA1 537/4885CA2 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.